
30 Jan 2020

Posted by Whitney Webb




DARPA recently spent millions on research involving bats and
coronaviruses, as well as gene editing “bioweapons” prior to the recent
coronavirus outbreak. Now, “strategic allies” of the agency have been
chosen to develop a genetic material-based vaccine to halt the potential
epidemic.
WASHINGTON D.C. – In recent weeks, concern
over the emergence of a novel coronavirus in China has grown
exponentially as media, experts and government officials around the
world have openly worried that this new disease has the potential to
develop into a global pandemic.
As concerns about the future of the ongoing outbreak have
grown, so too have the number of theories speculating about the
outbreak’s origin, many of which blame a variety of state actors and/or
controversial billionaires. This has inevitably led to efforts to clamp
down on “misinformation” related to the coronavirus outbreak from both
mainstream media outlets and major social media platforms.
However, while many of these theories are clearly
speculative, there is also verifiable evidence regarding the recent
interest of one controversial U.S. government agency in novel
coronaviruses, specifically those transmitted from bats to humans. That
agency, the Pentagon’s Defense Advanced Research Project Agency (DARPA),
began spending millions on such research in 2018 and some of those
Pentagon-funded studies were conducted at known U.S. military bioweapons
labs bordering China and resulted in the discovery of dozens of new
coronavirus strains as recently as last April. Furthermore, the ties of
the Pentagon’s main biodefense lab to a virology institute in Wuhan,
China — where the current outbreak is believed to have begun — have been
unreported in English language media thus far.
While it remains entirely unknown as to what caused the
outbreak, the details of DARPA’s and the Pentagon’s recent
experimentation are clearly in the public interest, especially
considering that the very companies recently chosen to develop a vaccine
to combat the coronavirus outbreak are themselves strategic allies of
DARPA. Not only that, but these DARPA-backed companies are developing
controversial DNA and mRNA vaccines for this particular coronavirus
strain, a category of vaccine that has never previously been approved
for human use in the United States.
Yet, as fears of the pandemic potential of coronavirus
grow, these vaccines are set to be rushed to market for public use,
making it important for the public to be aware of DARPA’s recent
experiments on coronaviruses, bats and gene editing technologies and
their broader implications.
Examining the recent Wuhan-Bioweapon narrative
Blogger's note:
subterrnews.blogspot.com does not send cookies, or collect any information on
those using the blog. However, the blogspot is on google, and google may
collect information, and send cookies. Many of the links that we
connect to do not send out cookies or collect information, but some do.
You are keying in to this blog, and you have agreed to this.
The views expressed in the articles
do not necessarily represent the opinions of this blog. They are the views, and opinions of the
author(s) of the article.